Subacute stent thrombosis following coronary angioplasty: incidence and risk factors.
Lesiak M, Grajek S, Pyda M, Skorupski W, Mitkowski P, Grygier M, Prech M, Paradowski S, Cieśliński A.
Kardiol Pol. 2003 Nov;59(11):408-16.
PMID:14668892
An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial.
Natsuaki M, Watanabe H, Morimoto T, Yamamoto K, Obayashi Y, Nishikawa R, Ando K, Domei T, Suwa S, Ogita M, Isawa T, Takenaka H, Yamamoto T, Ishikawa T, Hisauchi I, Wakabayashi K, Onishi Y, Hibi K, Kawai K, Yoshida R, Suzuki H, Nakazawa G, Kusuyama T, Morishima I, Ono K, Kimura T.
Circulation. 2024 Feb 20;149(8):585-600. doi: 10.1161/CIRCULATIONAHA.123.066720. Epub 2023 Nov 23.
PMID:37994553
Acute and subacute stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: incidence, predictors and clinical outcome.
Heestermans AA, van Werkum JW, Zwart B, van der Heyden JA, Kelder JC, Breet NJ, van't Hof AW, Dambrink JH, Koolen JJ, Brueren BR, Zijlstra F, ten Berg JM.
Diagnosis and Treatment of Subacute Right Coronary Artery Stent Thrombosis After Dual- Antiplatelet Therapy Interruption for Coronary Artery Bypass Grafting Surgery.
Gray L, Kuntz G, Ganapathi A, Bigelow G, Whitson B, Awad H, Graul T, Bailey T, Ryu J, Flores A, Essandoh M.